Reply to S. Di Cosimo et al.

Autor: Agostinetto E; Elisa Agostinetto, MD, David Venet, PhD, and Michail Ignatiadis, MD, PhD, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; and Ekaterina Kalashnikova, PhD, Natera, Inc, Austin, TX., Venet D; Elisa Agostinetto, MD, David Venet, PhD, and Michail Ignatiadis, MD, PhD, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; and Ekaterina Kalashnikova, PhD, Natera, Inc, Austin, TX., Ignatiadis M; Elisa Agostinetto, MD, David Venet, PhD, and Michail Ignatiadis, MD, PhD, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; and Ekaterina Kalashnikova, PhD, Natera, Inc, Austin, TX., Kalashnikova E; Elisa Agostinetto, MD, David Venet, PhD, and Michail Ignatiadis, MD, PhD, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; and Ekaterina Kalashnikova, PhD, Natera, Inc, Austin, TX.
Jazyk: angličtina
Zdroj: JCO precision oncology [JCO Precis Oncol] 2023 Jan; Vol. 7, pp. e2200644.
DOI: 10.1200/PO.22.00644
Databáze: MEDLINE